Sg2 Perspectives

48: What We Learned in 2020

In this week’s episode, Sg2’s Bill Woodson, Jennifer O’Connor and Henry Soch discuss the health care industry’s major learnings from 2020 and how leading health care provider organizations are applying those learnings to better prepare themselves for 2021 and beyond.

Sg2 members can register here for our annual The Year Ahead webinar on January 13 to learn about the unavoidable forces impacting the health care industry in 2021.

47: Academic Medical Centers Lead the Way in Novel Partnerships

COVID-19 continues to reveal existing gaps in the health care system; however, academic medical centers (AMCs) are leading the way in closing those gaps, as they increasingly turn to partnerships to serve populations with needs growing in depth and scope. In this week’s episode of Sg2 Perspectives, the Sg2 Intelligence Team’s Justin Cassidy, PhD, Director of Medicine, and Kelly Richard, Associate Principal, discuss the critical role of partnerships for AMCs as they evolve care delivery in the midst of the pandemic and beyond.

46: COVID-19’s Impact on Payer Mix Beyond 2020

COVID-19 has wreaked havoc on the economy, and health systems—despite serving a crucial clinical role—are not immune from its financial impact. This week on Sg2 Perspectives, Kelly and Trevor interview Tori Richie, Director on Sg2’s Intelligence team, about COVID-19’s effect on unemployment and insurance coverage, as the 3 of us play the role of experts in discussing the economic trends driving market-level payer mix.

45: New Consumer Patterns, Preferences and Possibilities

In this week’s episode, learn the results of Vizient’s latest consumer pulse survey from Mark Larson, Principal, Sg2 Intelligence, as well as Dr. Tom Villanueva, practicing internal medicine physician and Associate Vice President of Clinical Resources at Vizient, who will also share how patient preferences and expectations have changed in his practice.

Sg2 members can read more of our consumerism research here.

44: Rural Health During a Pandemic

Andrea Leslie, Regional President of four rural hospitals in Michigan’s Spectrum Health System, shares their unique rural challenges and the creative solutions they devised to keep their community and staff safe and healthy.

43: The Biggest Changes to the Prospective Payment System, Part 2 of 2

The Sg2 team of policy experts, Valinda Rutledge (former hospital CEO and leader of CMMI) and Leslie Kamel, unpack the proposed payment changes for virtual health and Chris Pagano, Senior Director of Virtual Health, explain the strategic implications for health systems.

42: The Biggest Changes to the Prospective Payment System, Part 1 of 2

The Sg2 team of policy experts, Valinda Rutledge (former hospital CEO and leader of CMMI) and Ryota Terada, Director Orthopedics and Policy, unpack the proposed payment changes around site of care and Chad Giese, Associate Principal Cardiovascular, explores the varying impact it will have across service lines.

41: The 2020 Election and Health Systems, Part 2: The Future of Insurance Coverage and Value-Based Payment

Health care is considered a high stakes issue in the 2020 presidential election in terms of both health insurance coverage and affordability of care. In Part 2 of Sg2 Perspectives’ 2-part election series, Vizient Senior Government Relations and Policy Director Steve Rixen once again joins Sg2’s Bill Woodson and Valinda Rutledge to discuss the potential fate of the Affordable Care Act as well as the path forward for value-based care.

40: The 2020 Election and Health Systems, Part 1: What Does the Election Outcome Mean for Drug Pricing?

All day, every day we are flooded with 2020 presidential election coverage, but rarely do we get a nuanced analysis of how a new or continued administration will impact policies most important to health systems. In Part 1 of Sg2 Perspective’s 2-part election series, we discuss one such policy as Vizient Senior Government Relations and Policy Director Steve Rixen joins Sg2’s Bill Woodson and Valinda Rutledge to discuss how a Trump administration or a Biden administration would likely address high drug costs and what that means for health system providers.

39: Academic Medical Centers of the Future: Destinations of Expertise

Sg2’s Principal Tawnya Bosko, DHA, and Senior Director Justin Cassidy, PhD, share insights on what the last six months of the pandemic looked like for academic medical centers, and how those challenges and adaptations are contributing to the evolution of their historic role from destinations for care to destinations of expertise.

Sg2 members can dive deeper with our AMC Resource Kit.

Contact the Sg2 team at sg2perspectives@sg2.com